Partnership Opportunities in Drug Delivery (PODD) Launches its 8th...

Partnership Opportunities in Drug Delivery (PODD) Launches its 8th year with Stellar Line up of Thought Leaders

By Pharma Tech Outlook | Monday, September 17, 2018

New York,NY - In its 8th year, Partnership Opportunities in Drug Delivery (PODD) will be held at the Westin Copley Place in Boston, MA from October 17-18, 2018.

Conference Chair, Barbara Lueckel, PhD, the Global Business Development Director for Roche Partnering Innovation opens the 8th annual event with a year in review on new science, deals, and technologies.

Annual keynote, Robert Langer, PhD, David H Koch Institute Professor at MIT will for the first time sit with investor Amy Schulman, Co-founder and CEO of Lyndra to discuss what makes drug delivery technologies and deals successful as well as what unmet needs remain.

Ms Schulman, who is also a venture Partner at Polaris Partners is an accomplished business leader, having overseen Pfizer’s acquisition of Wyeth and led Pfizer’s large Consumer Healthcare business.  She has also managed various start ups focused on drug delivery systems.

Also keynoting is Jeffrey Karp, PhD, Professor of Medicine at Harvard Medical School and Director of the Laboratory for Accelerated Medical Innovation at Brigham and Women’s Hospital and Justin Wright, PhD, Global Head of Innovation at Novartis.

Dr Karp will provide the bioinspirational keynote.  Dr Karp is a leading researcher in the fields of drug delivery, medical devices, stem cell therapeutics, and tissue adhesives. Dr Wright leads the drug development process for biologics and small molecules at Novartis.  He has developed models and partnerships in drug delivery innovation and has commercialized drug delivery systems for biotech, vaccine, and pharmaceutical industries.

“We are thrilled with the outstanding line up of some of the most influential thinkers in the drug delivery field, we are pleased with the continual growth of PODD and are happy to see how prominent this event has become in the industry,” noted Valerie Bowling, Director of the Conference Forum.

The speaking faculty as of September 12th also includes representation from GSK, Pfizer, BMS, Eli Lilly, Roche, Sanofi, Allergan, Genentech, Halozyme, Merck, AstraZeneca, and Novartis. 

PODD features an exhibit hall showcasing a wide range of products and solutions, as well as technology presentations from more than 45 companies covering:       

  -   Injectable technologies
   -  Oral, ophthalmic, & transmucosal technologies
   -  Device technologies
   -  Formulation technologies
   -  Transdermal & pulmonary technologies

The event is an opportunity for large and small players in the drug delivery field to learn more about innovations, network, and discover the most recent advancements across the field. PODD has a one-on-one partnering system to help facilitate business meetings.

Check This Out: Top Ophthalmic Companies

Weekly Brief

New Editions